Editorial introductions

Abstract

Current Opinion in Nephrology and Hypertension was launched in 1992. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of nephrology and hypertension is divided into 12 sections that are each reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue. SECTION EDITORS Agnes B. FogoAgnes B. FogoProf Agnes B. Fogo completed her medical training at Vanderbilt University Medical School, USA. She has remained at Vanderbilt for residency in pathology and for further training in renal pathology, with the late Dr Alan Glick, and also working in experimental renal diseases, with Dr Iekuni Ichikawa. Her main research interests are focused on progression of chronic kidney disease and the renin angiotensin aldosterone system and its link to the fibrinolytic/thrombolytic plasmin/plasminogen activator system. In recent years, she has explored the possibility of regression of sclerosis, pursued by funding from NIH and other sources. She is also dedicated to diagnostic renal pathology, and has created an online Atlas of Renal Pathology with the American Journal of Kidney Disease and the National Kidney Foundation. Prof Fogo enjoys being involved with teaching renal pathology, and received the Robert G. Narins award from the ASN in 2011 for her contributions in teaching. She is currently the John L. Shapiro professor of pathology, microbiology and immunology, professor of medicine and pediatrics and director of the Renal/Electron Microscopy Laboratory, at Vanderbilt University Medical Center. Navdeep TangriNavdeep TangriDr Navdeep Tangri is an attending physician and Associate Professor in the Division of Nephrology, Department of Medicine at the University of Manitoba, Canada. He is also a Director of the Chronic Disease Innovation Center at Seven Oaks Hospital in Winnipeg, Canada. Dr Tangri's research program is clinical and translational and focused on improving clinical decision making for patients with chronic kidney disease. He developed and validated the Kidney Failure Risk Equation to predict the need for dialysis in patients with CKD, and is presently engaged in multiple implementation trials to increase the global uptake of the KFRE. In addition, Dr Tangri is conducting a large prospective study on frailty, physical and cognitive function in advanced CKD, as well as comparative effectiveness studies on the safety and effectiveness of medical therapies in this population. He has published over 120 manuscripts and presented at several national and international scientific meetings. Dr Tangri reviews manuscripts for several major medical journals, including the Annals of Internal Medicine, the Journal of American Society of Nephrology, and the Journal of the American Medical Association. He sits of the editorial board of the American Journal of Kidney Disease, Canadian Journal of Kidney Health and Disease and is Section Editor of Current Opinion in Nephrology and Hypertension. He has active grants from the Canadian Institute of Health Research, the Kidney Foundation of Canada and the Manitoba Health Research Council. In addition, he is co-chair of the scientific committee of the Canadian Society of Nephrology, and a member of the American Society of Nephrology and the International Society of Nephrology. Dr Tangri received his medical degree from the University of Manitoba, Winnipeg, Manitoba Canada. He completed his residency program in internal medicine at McGill University, Montreal, Quebec, Canada, and completed his nephrology training and doctoral degree at Tufts Medical Center, Tufts University, in Boston, Massachusetts, USA. He then moved to the University of Manitoba where he has been a full time faculty member since 2011.